% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hemminki:157416,
author = {K. Hemminki$^*$ and A. Srivastava$^*$ and S. Rachakonda$^*$
and O. Bandapalli$^*$ and E. Nagore and A. Hemminki and R.
Kumar$^*$},
title = {{I}nforming patients about their mutation tests: {CDKN}2{A}
$c.256{G}\>{A}$ in melanoma as an example.},
journal = {Hereditary cancer in clinical practice},
volume = {18},
number = {1},
issn = {1897-4287},
address = {Heidelberg},
publisher = {Springer},
reportid = {DKFZ-2020-01611},
pages = {15},
year = {2020},
note = {#EA:C050#EA:C020#LA:B070#LA:C050},
abstract = {When germline mutations are suspected as causal in cancer,
patient DNA may be sequenced to detect variants in relevant
genes. If a particular mutation has not been reported in
reliable family studies, genetic counselors are facing a
dilemma of appropriately informing patients. Many sequencing
facilities provide an interpretation of the findings based
on the available sequence databases or on prediction tools
that are curated from bioinformatics and mechanistic
datasets. The counseling dilemma is exacerbated if the
pedigree data are not informative but the in silico
predictions suggest pathogenicity.We present here a real
world example of the c.256G > A CDKN2A variant, which
was detected in one melanoma patient where two siblings were
diagnosed with melanoma in situ. We investigated a detailed
family history of the affected siblings in order to survey
probability of the cancer risks within the context to this
mutation.This c.256G > A CDKN2A variant was detected in
one of the brothers and in the melanoma-free mother while
the other brother in the family tested negative. The variant
had been previously described in one patient from a melanoma
family. In the family under investigation, the mother's 16
first-and second-degree relatives had survived past the
median onset age for melanoma and none presented melanoma.
We tested the variant using multiple bioinformatic tools
that all predicted deleteriousness of the variant. The
genetic counseling report to the melanoma patient stated
that the CDKN2A variant was 'likely pathogenic' and the
disease was defined as 'likely hereditary melanoma'.The
pedigree data showed at the most a low penetrance variant,
which, if taken into consideration, might have altered the
provided diagnosis. When dealing with 'practically' unknown
variants the counselors would be advised to incorporate a
detailed family history rather than basing predictions on
functionality provided by sequencing facilities.},
cin = {C050 / B062 / B070 / HD01},
ddc = {610},
cid = {I:(DE-He78)C050-20160331 / I:(DE-He78)B062-20160331 /
I:(DE-He78)B070-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32760473},
pmc = {pmc:PMC7393828},
doi = {10.1186/s13053-020-00146-x},
url = {https://inrepo02.dkfz.de/record/157416},
}